A role for tumor necrosis factor-α in experimental Bacillus cereus endophthalmitis pathogenesis

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 10, 2008, Pages 4482-4489

  Ramadan, Raniyah T ^a   Moyer, Andrea L ^b   Callegan, Michelle C ^a,b,c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; INFLIXIMAB; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLUS CEREUS; BACILLUS CEREUS INFECTION; BACTERIAL COUNT; BACTERIAL GROWTH; CONTROLLED STUDY; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; EXPERIMENTAL INFECTION; EYE; FEMALE; HISTOLOGY; KNOCKOUT MOUSE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA; TISSUE STRUCTURE; VITREOUS BODY; WILD TYPE; ANIMAL; BACTERIAL EYE INFECTION; BACTERIAL INFECTION; C57BL MOUSE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; NEUTROPHIL; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; BACILLUS CEREUS; COLONY COUNT, MICROBIAL; CYTOKINES; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PEROXIDASE; POLYMERASE CHAIN REACTION; RETINA; TUMOR NECROSIS FACTOR-ALPHA; VITREOUS BODY;

EID: 53449102895     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2085     Document Type: Article

References (64)

1. Callegan MC, Gilmore MS, Gregory M, et al. Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions. Prog Retin Eye Res. 2007;26(2):189-203. (Pubitemid 46217162)
2. Das T, Choudhury K, Sharma S, Jalali S, Nuthethi R. Endophthalmitis Research Group: clinical profile and outcome in Bacillus endophthalmitis. Ophthalmology. 2001;108(10):1819-1825. (Pubitemid 32910243)
3. David DB, Kirkby GR, Noble BA. Bacillus cereus endophthalmitis. Br J Ophthalmol. 1994;78(7):577-580.
4. Miller JJ, Scott IU, Flynn HW Jr, et al. Endophthalmitis caused by Bacillus species. Am J Ophthalmol. 2008;145(5):883-888.
5. Booth MC, Cheung AL, Hatter KL, Jett BD, Callegan MC, Gilmore MS. Staphylococcal accessory regulator (SAR) in conjunction with AGR contributes to Staphylococcus aureus virulence in endophthalmitis. Infect Immun. 1997;65(4):1550-1556.
6. Booth MC, Atkuri RV, Nanda SK, Iandolo JJ, Gilmore MS. Accessory gene regulator controls Staphylococcus aureus virulence in endophthalmitis. Invest Ophthalmol Vis Sci. 1995;36(9):1828-1836.
7. Callegan MC, Jett BD, Hancock LE, Gilmore MS. Role of hemolysin BL in the pathogenesis of extraintestinal Bacillus cereus infection assessed in an endophthalmitis model. Infect Immun. 1999;67(7):3357-3366.
8. Callegan MC, Cochran DC, Kane ST, Gilmore MS, Gominet M, Lereclus D. Contribution of membrane-damaging toxins to Bacillus endophthalmitis pathogenesis. Infect Immun. 2002;70(10):5381-5389. (Pubitemid 35050970)
9. Callegan MC, Kane ST, Cochran DC, Gilmore MS, Gominet M, Lereclus D. Relationship of plcR-regulated factors to Bacillus endophthalmitis virulence. Infect Immun. 2003;71(6):3116-3124. (Pubitemid 36637533)
10. Jett BD, Jensen HG, Nordquist RE, Gilmore MS. Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthalmitis. Infect Immun. 1992;60(6):2445-2452.
11. Jett BD, Jensen HG, Atkuri RV, Gilmore MS. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains. Invest Ophthalmol Vis Sci. 1995;36(1):9-15.
12. Giese MJ, Rayner SA, Fardin B, et al. Mitigation of neutrophil infiltration in a rat model of early Staphylococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci. 2003;44(7):3077-3082. (Pubitemid 36759775)
13. Ramadan RT, Ramirez R, Novosad BD, Callegan MC. Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. Curr Eye Res. 2006;31(11):955-965. (Pubitemid 44777373)
14. Giese MJ, Sumner HL, Berliner JA, Mondino BJ. Cytokine expression in a rat model of Staphylococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci. 1998;39(13):2785-2790.
15. Ravindranath RM, Hasan SA, Mondino BJ. Immunopathologic features of Staphylococcus epidermidis-induced endophthalmitis in the rat. Curr Eye Res. 1997;16(10):1036-1043.
16. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med. 1996;334(26):1717-1725. (Pubitemid 26193625)
17. Petropoulos IK, Vantzou CV, Lamari FN, Karamanos NK, Anastassiou ED, Pharmakakis NM. Expression of TNF-alpha, IL-1beta, and IFN-gamma in Staphylococcus epidermidis slime-positive experimental endophthalmitis is closely related to clinical inflammatory scores. Graefes Arch Clin Exp Ophthalmol. 2006;244(10):1322-1328.
18. Luna JD, Chan CC, Derevjanik NL, et al. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta- mediated breakdown. J Neurosci Res. 1997;49(3):268-280.
19. De Vos AF, Van Haren MA, Verhagen C, Hoekzema R, Kijlstra A. Tumour necrosis factor-induced uveitis in the Lewis rat is associated with intraocular interleukin 6 production. Exp Eye Res. 1995;60(2):199-207.
20. Dick AD, Forrester JV, Liversidge J, Cope AP. The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU). Prog Retin Eye Res. 2004;23(6):617-637. (Pubitemid 39243969)
21. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med. 1996;184(4):1397-1411. (Pubitemid 26354696)
22. Jett BD, Hatter KL, Huycke MM, Gilmore MS. Simplified agar plate method for quantifying viable bacteria. BioTechniques. 1997;23(4):648-650.
23. Ohta K, Yamagami S, Wiggert B, Dana MR, Streilein JW. Chemokine gene expression in iris-ciliary body during experimental autoimmune uveoretinitis. Curr Eye Res. 2002;24(6):451-457. (Pubitemid 36126762)
24. Xue ML, Thakur A, Willcox M. Gene expression of pro-inflammatory cytokines and chemokines in mouse eye infected with Pseudomonas aeruginosa. Clin Exp Ophthalmol. 2002;30(3):196-199. (Pubitemid 34578169)
25. Nishida T, Miyata S, Itoh Y, et al. Anti-inflammatory effects of alpha-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor. Int Immunopharmacol. 2004;4(8):1059-1066. (Pubitemid 38844180)
26. Cole N, Hume E, Khan S, et al. Contribution of the cornea to cytokine levels in the whole eye induced during the early phase of Pseudomonas aeruginosa challenge. Immunol Cell Biol. 2005;83(3):301-306. (Pubitemid 40799559)
27. Lin M, Carlson E, Diaconu E, Pearlman E. CXCL1/KC and CXCL5/LIX are selectively produced by corneal fibroblasts and mediate neutrophil infiltration to the corneal stroma in LPS keratitis. J Leukoc Biol. 2007;81(3):786-792. (Pubitemid 46393556)
28. Engelbert M, Gilmore MS. Fas ligand but not complement is critical for control of experimental Staphylococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci. 2005;46(7):2479-2486. (Pubitemid 43119497)
29. Stenzel W, Soltek S, Miletic H, et al. An essential role for tumor necrosis factor in the formation of experimental murine Staphylococcus aureus-induced brain abscess and clearance. J Neuropathol Exp Neurol. 2005;64(1):27-36. (Pubitemid 40189476)
30. Kielian T, Bearden ED, Baldwin AC, Esen N. IL-1 and TNF-alpha play a pivotal role in the host immune response in a mouse model of Staphylococcus aureus-induced experimental brain abscess. J Neuropathol Exp Neurol. 2004;63(4):381-396. (Pubitemid 38429034)
31. Marino MW, Dunn A, Grail D, et al. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A. 1997;94(15):8093-8098. (Pubitemid 27343782)
32. Wellmer A, Gerber J, Ragheb J, et al. Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis. Infect Immun. 2001;69(11):6881-6886. (Pubitemid 32995447)
33. Kirby AC, Raynes JG, Kaye PM. The role played by tumor necrosis factor during localized and systemic infection with Streptococcus pneumoniae. J Infect Dis. 2005;191(9):1538-1547.
34. Derevjanik NL, Vinores SA, Xiao WH, et al. Quantitative assessment of the integrity of the blood-retinal barrier in mice. Invest Ophthalmol Vis Sci. 2002;43(7):2462-2467.
35. Vinores SA, Xiao WH, Shen J, Campochiaro PA. TNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage. J Neuroimmunol. 2007;182(1-2):73-79. (Pubitemid 46039759)
36. Mazzon E, Cuzzocrea S. Role of TNF-alpha in lung tight junction alteration in mouse model of acute lung inflammation. Respir Res. 2007;8:75.
37. Mazzon E, Cuzzocrea S. Role of TNF-alpha in ileum tight junction alteration in mouse model of restraint stress. Am J Physiol Gastrointest Liver Physiol. 2008;294(5):G1268-G1280.
38. Kuprash DV, Tumanov AV, Liepinsh DJ, et al. Novel tumor necrosis factor-knockout mice that lack Peyer's patches. Eur J Immunol. 2005;35(5):1592-1600.
39. Vasanthi M, Prajna NV, Lalitha P, Mahadevan K, Muthukkaruppan V. A pilot study on the infiltrating cells and cytokine levels in the tear of fungal keratitis patients. Indian J Ophthalmol. 2007;55(1):27-31. (Pubitemid 46065929)
40. Chintakuntlawar AV, Astley R, Chodosh J. Adenovirus type 37 keratitis in the C57BL/6J mouse. Invest Ophthalmol Vis Sci. 2007;48(2):781-788. (Pubitemid 351260713)
41. Cole N, Bao S, Thakur A, Willcox M, Husband AJ. KC production in the cornea in response to Pseudomonas aeruginosa challenge. Immunol Cell Biol. 2000;78(1):1-4. (Pubitemid 30090982)
42. Hume EB, Cole N, Khan S, et al. A Staphylococcus aureus mouse keratitis topical infection model: cytokine balance in different strains of mice. Immunol Cell Biol. 2005;83(3):294-300. (Pubitemid 40799558)
43. Fodor M, Facskó A, Rajnavölgyi E, et al. Enhanced release of IL-6 and IL-8 into tears in various anterior segment eye diseases. Ophthalmic Res. 2006;38(4):182-188. (Pubitemid 44213977)
44. Sijssens KM, Rijkers GT, Rothova A, Stilma JS, Schellekens PA, de Boer JH. Cytokines, chemokines and soluble adhesion molecules in aqueous humor of children with uveitis. Exp Eye Res. 2007;85(4):443-449. (Pubitemid 47542266)
45. Xu Y, Hunt NH, Bao S. The correlation between proinflammatory cytokines, MAdCAM-1 and cellular infiltration in the inflamed colon from TNF-alpha gene knockout mice. Immunol Cell Biol. 2007;85(8):633-639. (Pubitemid 350224210)
46. Yimin, Kohanawa M. A regulatory effect of the balance between TNF-alpha and IL-6 in the granulomatous and inflammatory response to Rhodococcus aurantiacus infection in mice. J Immunol. 2006;177(1):642-650.
47. Moore TA, Lau HY, Cogen AL, Standiford TJ. Defective innate antibacterial host responses during murine Klebsiella pneumoniae bacteremia: tumor necrosis factor (TNF) receptor 1 deficiency versus therapy with anti-TNF-alpha. Clin Infect Dis. 2005;41(suppl 3):S213-S217.
48. Nakazawa T, Matsubara A, Noda K, et al. Characterization of cytokine responses to retinal detachment in rats. Mol Vis. 2006;7:12:867-878. (Pubitemid 44184719)
49. Zeng HY, Zhu XA, Zhang C, Yang LP, Wu LM, Tso MO. Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice. Invest Ophthalmol Vis Sci. 2005;46(8):2992-2999. (Pubitemid 43086724)
50. Yoshida S, Yoshida A, Ishibashi T. Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation. Graefes Arch Clin Exp Ophthalmol. 2004;242(5):409-413. (Pubitemid 38801529)
51. Vinores SA, Derevjanik NL, Shi A, Vinores MA, Klein DA, Whittum-Hudson JA. Vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGFbeta), and interleukin-6 (IL-6) in experimental herpesvirus retinopathy: association with inflammation and viral infection. Histol Histopathol. 2001;16(4):1061-1071. (Pubitemid 32994451)
52. Cotinet A, Goureau O, Thillaye-Goldenberg B, Naud MC, de Kozak Y. Differential tumor necrosis factor and nitric oxide production in retinal Müller glial cells from C3H/HeN and C3H/HeJ mice. Ocul Immunol Inflamm. 1997;5(2):111-116. (Pubitemid 27299999)
53. Drescher KM, Whittum-Hudson JA. Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells. Invest Ophthalmol Vis Sci. 1996;37(11):2302-2312.
54. Brito BE, O'Rourke LM, Pan Y, Anglin J, Planck SR, Rosenbaum JT. IL-1 and TNF receptor-deficient mice show decreased inflammation in an immune complex model of uveitis. Invest Ophthalmol Vis Sci. 1999;40(11):2583-2589. (Pubitemid 29455487)
55. Olson JL, Courtney RJ, Mandava N. Intravitreal infliximab and choroidal neovascularization in an animal model. Arch Ophthalmol. 2007;125(9):1221-1224. (Pubitemid 47403029)
56. Shi X, Semkova I, Müther PS, Dell S, Kociok N, Joussen AM. Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization. Exp Eye Res. 2006;83(6):1325-1334. (Pubitemid 44648092)
57. Diaz-Llopis M, García-Delpech S, Salom D, et al. High-dose infliximab prophylaxis in endotoxin-induced uveitis. J Ocul Pharmacol Ther. 2007;23(4):343-350. (Pubitemid 350195058)
58. Gallagher M, Quinones K, Cervantes-Castañeda RA, Yilmaz T, Foster CS. Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol. 2007;91(10):1341-1344. (Pubitemid 47492870)
59. Abu El-Asrar AM, Abboud EB, Aldibhi H, Al-Arfaj A. Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet's disease. Int Ophthalmol. 2005;26(3):83-92. (Pubitemid 44781873)
60. Suhler EB, Smith JR, Wertheim MS, et al. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol. 2005;123(7):903-912. (Pubitemid 41057986)
61. Galor A, Perez VL, Hammel JP, Lowder CY. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology. 2006;113(12):2317-2323. (Pubitemid 44838928)
62. Rajaraman RT, Kimura Y, Li S, Haines K, Chu DS. Retrospective case review of pediatric patients with uveitis treated with infliximab. Ophthalmology. 2006;113(2):308-314. (Pubitemid 43170781)
63. Giansanti F, Ramazzotti M, Vannozzi L, et al. A pilot study on ocular safety of intravitreal infliximab in a rabbit model. Invest Ophthalmol Vis Sci. 2008;49(3):1151-1156.
64. Wiskur BW, Robinson M, Farrand A, Novosad B, Callegan MC. Improved therapeutic regimens for Bacillus endophthalmitis. Invest Ophthalmol Vis Sci. 2008;49(4):1480-1487.